Tag Archives: The Stem Cell Blog

Merck, riding clinical success, eyes cancer immunotherapy lead – BioPharma Dive

Continue reading

2018-05-01 NEWS

Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of …
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 NEWS

Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of …
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 NEWS

Eureka Times Standard

UC vs. Harvard: Round 2 in CRISPR gene technology fight
Eureka Times Standard
It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides …